163 related articles for article (PubMed ID: 1728639)
21. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
Pontzer CH; Russell JK; Johnson HM
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
Scholl PR; Diez A; Geha RS
J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
[TBL] [Abstract][Full Text] [Related]
23. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.
Gonzalo JA; Moreno de Alborán I; Alés-Martínez JE; Martínez C; Kroemer G
Eur J Immunol; 1992 Apr; 22(4):1007-11. PubMed ID: 1551401
[TBL] [Abstract][Full Text] [Related]
24. Bacterial superantigens induce V beta-specific T cell receptor internalization.
Makida R; Hofer MF; Takase K; Cambier JC; Leung DY
Mol Immunol; 1996 Jul; 33(10):891-900. PubMed ID: 8845021
[TBL] [Abstract][Full Text] [Related]
25. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
26. Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens.
Stuyt RJ; Netea MG; Kim SH; Novick D; Rubinstein M; Kullberg BJ; Van der Meer JW; Dinarello CA
Infect Immun; 2001 Aug; 69(8):5025-30. PubMed ID: 11447182
[TBL] [Abstract][Full Text] [Related]
27. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
29. Bacterial superantigens induce the proliferation of resting gamma/delta receptor bearing T cells.
Ramesh N; Horner A; Ahern D; Geha RS
Immunol Invest; 1995 Aug; 24(5):713-24. PubMed ID: 8543336
[TBL] [Abstract][Full Text] [Related]
30. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
31. Costimulatory molecule requirement for bovine WC1+gammadelta T cells' proliferative response to bacterial superantigens.
Fikri Y; Pastoret PP; Nyabenda J
Scand J Immunol; 2002 Apr; 55(4):373-81. PubMed ID: 11967119
[TBL] [Abstract][Full Text] [Related]
32. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
Wood SC; Holsapple MP
Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of B10.BR T cells with superantigenic staphylococcal toxins.
Callahan JE; Herman A; Kappler JW; Marrack P
J Immunol; 1990 Apr; 144(7):2473-9. PubMed ID: 2138648
[TBL] [Abstract][Full Text] [Related]
34. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
35. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
Lussow AR; MacDonald HR
Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
[TBL] [Abstract][Full Text] [Related]
37. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation.
Poncet P; Arock M; David B
J Leukoc Biol; 1999 Jul; 66(1):105-12. PubMed ID: 10410997
[TBL] [Abstract][Full Text] [Related]
38. Study of activation of murine T cells with bacterial superantigens. In vitro induction of enhanced responses in CD4+ T cells and of anergy in CD8+ T cells.
Yan XJ; Li XY; Imanishi K; Kumazawa Y; Uchiyama T
J Immunol; 1993 May; 150(9):3873-81. PubMed ID: 8097227
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of rat spleen cells by staphylococcal enterotoxins.
Holbrook MR; Young KE; Gibbon LG; Webster CA; Tranter HS; Arbuthnott JP; Todd I
FEMS Immunol Med Microbiol; 1993 Aug; 7(2):169-74. PubMed ID: 8401429
[TBL] [Abstract][Full Text] [Related]
40. In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis.
Bour H; Demidem A; Garrigue JL; Krasteva M; Schmitt D; Claudy A; Nicolas JF
Acta Derm Venereol; 1995 May; 75(3):218-21. PubMed ID: 7653183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
